Skip to content

Persian Medicine dietary recommendations in nocturnal enuresis in children

Comparison of Persian Medicine dietary recommendations versus Desmopressin on treatment of primary nocturnal enuresis in children

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210815052184N2
Enrollment
68
Registered
2021-10-10
Start date
2021-10-23
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary nocturnal enuresis of children. Nocturnal enuresis

Interventions

Intervention 1: Intervention group: Abstinence and dietary recommendations of Persian medicine for 6 weeks including avoiding any liquids and drinks at night and before bed, reduce dinner, avoid cold

Sponsors

Research institute for Children's Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 15 Years

Inclusion criteria

Inclusion criteria: 6-15 years children with monosymptomatic primary nocturnal enuresis No concomitant pharmacological or non-pharmacological treatments or other methods of complementary medicine Parents' willingness to participate in the research

Exclusion criteria

Exclusion criteria: Enuresis due to UTI, diabetes insipidus (DI), diabetes mellitus (DM), Seizures and side effects Daily urinary incontinence child with neurogenic bladder Urinary anatomical problems like Posterior Urethral Valve (PUV) or Urethral obstruction History of treatment with desmopressin in the past year Chronic UTI previous urinary tract surgery

Design outcomes

Primary

MeasureTime frame
Frequency of enuresis. Timepoint: The number of enuresis at the beginning of the study (before the intervention) and during the 6 weeks of treatment is recorded by the parents in the questionnaire every day. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public Contact??Dr. Monireh Sadat Motaharifard

Research institute for Children's Health

ms.motaharifard@sbmu.ac.ir+98 21 2222 9658

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026